0000899243-20-025437.txt : 20200916
0000899243-20-025437.hdr.sgml : 20200916
20200916204417
ACCESSION NUMBER: 0000899243-20-025437
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200916
FILED AS OF DATE: 20200916
DATE AS OF CHANGE: 20200916
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CureDuchenne Ventures, LLC
CENTRAL INDEX KEY: 0001824590
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39509
FILM NUMBER: 201179921
BUSINESS ADDRESS:
STREET 1: 1400 QUAIL STREET
STREET 2: SUITE 110
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
BUSINESS PHONE: 949-872-2552
MAIL ADDRESS:
STREET 1: 1400 QUAIL STREET
STREET 2: SUITE 110
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dyne Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818794
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364883909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 786-8230
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-09-16
0
0001818794
Dyne Therapeutics, Inc.
DYN
0001824590
CureDuchenne Ventures, LLC
1400 QUAIL STREET SUITE 110
NEWPORT BEACH
CA
92660
0
0
1
0
Series A Preferred Stock
Common Stock
602972
D
The Series A Preferred Stock is convertible into common stock on a 3.3169-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
CureDuchenne Ventures, LLC, By: /s/ Debra Miller, Chief Executive Officer
2020-09-16